OliX Pharmaceuticals, Inc (KOSDAQ: 226950)

OliX Pharmaceuticals Revenue

OliX Pharmaceuticals had revenue of 4.60B KRW in the quarter ending June 30, 2024, with 102.06% growth. This brings the company's revenue in the last twelve months to 17.90B, up 85.23% year-over-year. In the year 2023, OliX Pharmaceuticals had annual revenue of 17.06B with 83.09% growth.

• Revenue (ttm): 17.90B
• Revenue Growth: +85.23%
• P/S Ratio: 14.90
• Revenue / Employee: 248.60M
• Employees: 72
• Market Cap: 286.01B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	17.06B	7.74B	83.09%
Dec 31, 2022	9.32B	5.65B	153.66%
Dec 31, 2021	3.67B	1.20B	48.50%
Dec 31, 2020	2.47B	1.34B	118.90%
Dec 31, 2019	1.13B	828.33M	274.28%